The comparison of nasal irrigation outcome between 3% NaCl and 0.9% NaCl in adults majority with intermittent allergic rhinitis: A randomized double-blind study

被引:2
|
作者
Yata, Kedsaraporn [1 ]
Srivanitchapoom, Chonticha [1 ]
机构
[1] Phayao Hosp, Otolaryngol Unit, 269 Moo 11, Muang Phayao, Phayao, Thailand
关键词
nasal irrigation; 3% NaCl; 0.9% NaCl; hypertonic saline; allergic rhinitis; HYPERTONIC SALINE; MUCOCILIARY CLEARANCE; CHILDREN; ASTHMA; CONGESTION; IMPACT;
D O I
10.12932/AP-140520-0844
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Management of allergic rhinitis with oral antihistamine and steroid nasal spray are the standard treatment which is recommended by Allergic Rhinitis and its Impact on Asthma guidelines. In addition, nasal irrigation as an adjuvant therapy also provides a satisfactory result. Objective: To compare the treatment outcome in adults majority with intermittent allergic rhinitis who receive different concentrations of nasal irrigation. Methods: The prospective randomized double-blind study was performed in 80 patients. All patients were prescribed oral antihistamine and nasal irrigated solution between 3% NaCl and 0.9% NaCl. Nasal congestion and rhinorrhea were evaluated at baseline, first and second weeks after treatment. Assessments were measured by nasal congestion visual analog scale rhinorrhea visual analog scale, inferior turbinate size, and peak nasal expiratory flow rate (PNEFR). A p value of < 0.05 was considered statistically significant. Results: There were 40 patients in each group of the study. Patients reported satisfactory experience after using saline irrigation at first and second weeks in both solutions (p value < 0.001). However, when compared between groups, no significant differences for all parameters were reported. PNEFR showed good results after the first week of 3% NaCl irrigation (p value = 0.001), while 0.9% NaCl had good results after the second week (p value < 0.001). Conclusion: Both add-on treatments have a significant improvement of all 4 parameters assessed in the study: nasal congestion, rhinorrhca, inferior turbinate size and PNEFR. Of note, 3% NaCl but not 0.9 NaCl had improved the PNEFR earlier from 1 week of the treatment.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [11] A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic Rhinitis
    Han, Demin
    Chen, Lei
    Cheng, Lei
    Liu, Shixi
    Fu, Zheng
    Zhang, Wei
    Wang, Chengshuo
    Xi, Lin
    Zhang, Luo
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2011, 73 (05): : 260 - 265
  • [12] Allergic Rhinitis Improvement in Asthmatic Children After Using Acaricidal Bait: A Randomized, Double-Blind, Cross-Placebo Study
    Chen, Ming
    Wu, Yufen
    Yuan, Shuhua
    Tang, Mingyu
    Zhang, Lei
    Chen, Jiande
    Li, Luanluan
    Wu, Jinhong
    Zhang, Jing
    Yin, Yong
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [13] Therapeutic Effects of Fermented Red Ginseng in Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Study
    Jung, Jae-Woo
    Kang, Hye-Ryun
    Ji, Geun-Eog
    Park, Myeong-Soo
    Song, Woo-Jung
    Kim, Min-Hye
    Kwon, Jae-Woo
    Kim, Tae-Whan
    Park, Heung-Woo
    Cho, Sang-Heon
    Min, Kyung-Up
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2011, 3 (02) : 103 - 110
  • [14] A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis
    Herman, D
    Garay, R
    LeGal, M
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 1997, 39 (01) : 1 - 8
  • [15] Effects of Olopatadine Hydrochloride Nasal Spray 0.6% in the Treatment of Seasonal Allergic Rhinitis: A Phase III, Multicenter, Randomized, Double-Blind, Active- and Placebo-Controlled Study in Adolescents and Adults
    Shah, Shailen R.
    Nayak, Anjuli
    Ratner, Paul
    Roland, Peter
    Wall, G. Michael
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 99 - 107
  • [16] Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study
    Rimmer, J.
    Peake, H. L.
    Santos, C. M. C.
    Lean, M.
    Bardin, P.
    Robson, R.
    Haumann, B.
    Loehrer, F.
    Handel, M. L.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (01) : 8 - 14
  • [17] Randomized double-blind placebo-controlled crossover study of efficacy of pollen blocker cream for perennial allergic rhinitis
    Li, Yanqing
    Wang, Dehui
    Liu, Quan
    Liu, Juan
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2013, 27 (04) : 299 - 303
  • [18] A Randomized, Double-Blind, Placebo-Controlled Exploratory Study to evaluate the potential of Pycnogenol® for Improving Allergic Rhinitis Symptoms
    Wilson, Dale
    Evans, Malkanthi
    Guthrie, Najla
    Sharma, Prachi
    Baisley, Joshua
    Schonlau, Frank
    Burki, Carolina
    PHYTOTHERAPY RESEARCH, 2010, 24 (08) : 1115 - 1119
  • [19] Association between desloratadine and prednisolone in the treatment of children with acute symptoms of allergic rhinitis: a double-blind, randomized and controlled clinical trial
    Wandalsen, Gustavo F.
    Miranda, Carolina
    Ensina, Luis Felipe
    Sano, Flavio
    Amazonas, Roberto Bleul
    da Silva, Joyce Macedo
    Sole, Dirceu
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2017, 83 (06) : 633 - 639
  • [20] A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial
    Esmaeilzadeh, Hossein
    Far, Nasrin Mortazavi
    Nabavizadeh, Seyed Hesamedin
    Babaeian, Masroor
    Hadipour, Maryam
    Alyasin, Soheila
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2022, 36 (05) : 559 - 567